Open Access

Silencing of RIPK4 inhibits epithelial‑mesenchymal transition by inactivating the Wnt/β‑catenin signaling pathway in osteosarcoma

  • Authors:
    • Zhigang Yi
    • Yanchuan Pu
    • Ruoyan Gou
    • Yonggang Chen
    • Xiaojun Ren
    • Wenzhong Liu
    • Ping Dong
  • View Affiliations

  • Published online on: January 14, 2020     https://doi.org/10.3892/mmr.2020.10939
  • Pages: 1154-1162
  • Copyright: © Yi et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Receptor interacting protein kinase 4 (RIPK4) is a serine/threonine kinase that plays an important role in the regulation of cell proliferation, invasion and metastasis in several malignancies; however, its clinical significance and biological function in osteosarcoma (OS) remains unknown. In the present study, the RIPK4 expression level was significantly upregulated in OS tissues and cell lines. High RIPK4 expression was positively associated with larger sized tumors, advanced Enneking stage and poor prognosis in patients with OS. Furthermore, the results revealed that RIPK4 knockdown in the OS cell lines MG‑63 and U2OS reduced cell migration and invasion via the inhibition of epithelial‑mesenchymal transition (EMT) process, whereby E‑cadherin expression was increased and N‑cadherin and vimentin expression decreased. Mechanistically, RIPK4 knockdown inhibited EMT by inactivating the Wnt/β‑catenin signaling pathway. These findings suggest that RIPK4 may be a novel potential therapeutic target for the treatment of metastases in patients with OS.
View Figures
View References

Related Articles

Journal Cover

March 2020
Volume 21 Issue 3

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
APA
Yi, Z., Pu, Y., Gou, R., Chen, Y., Ren, X., Liu, W., & Dong, P. (2020). Silencing of RIPK4 inhibits epithelial‑mesenchymal transition by inactivating the Wnt/β‑catenin signaling pathway in osteosarcoma. Molecular Medicine Reports, 21, 1154-1162. https://doi.org/10.3892/mmr.2020.10939
MLA
Yi, Z., Pu, Y., Gou, R., Chen, Y., Ren, X., Liu, W., Dong, P."Silencing of RIPK4 inhibits epithelial‑mesenchymal transition by inactivating the Wnt/β‑catenin signaling pathway in osteosarcoma". Molecular Medicine Reports 21.3 (2020): 1154-1162.
Chicago
Yi, Z., Pu, Y., Gou, R., Chen, Y., Ren, X., Liu, W., Dong, P."Silencing of RIPK4 inhibits epithelial‑mesenchymal transition by inactivating the Wnt/β‑catenin signaling pathway in osteosarcoma". Molecular Medicine Reports 21, no. 3 (2020): 1154-1162. https://doi.org/10.3892/mmr.2020.10939